Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | market report | table of contents
Belgium Pharmaceuticals and Healthcare Report Q3 2008 (Business Monitor International)
- Market: Healthcare and Medical
- Report Title: Belgium Pharmaceuticals and Healthcare Report Q3 2008
- View Report Summary: View Report Summary
- Report Type: Market Report
- Country: Belgium
- Number of Pages: 66
Executive Summary ........5
Belgium Pharmaceuticals And Healthcare Industry SWOT... 6
Belgium Political SWOT . 6
Belgium Economic SWOT.......... 7
Pharmaceutical Business Environment Ratings ..........8
Table: Western Europe Pharmaceutical Business Environment Ratings . 8
Limits Of Potential Returns........ 8
Belgium – Market Summary ...........10
Regulatory Regime .........11
Intellectual Property Developments............... 12
Pricing And Reimbursement Regime.............. 13
Pricing And Reimbursement Developments ... 14
Industry Developments .......16
Healthcare Sector ......... 16
Recent Healthcare Sector Developments ....... 17
Epidemiology ................ 18
Table: Disease Burden In Western Europe.... 19
Operating Environment And Recent Company Developments ............... 20
Generics Sector ............. 22
Research And Development Sector ................ 24
Industry Forecast Scenario ..25
Overall Market Forecast.......... 25
Table: Belgium’s Drug Market Indicators, 2005-2012........ 26
Key Growth Factors – Industry 27
Table: Belgium’s Health Expenditure Indicators, 2005-20 28
Key Growth Factors – Macroeconomic ......... 29
Table: Belgium - Economic Activity............... 31
Patented Market Forecast........ 32
Table: Belgium’s Patented Drugs Market Indicators, 2006-2012 .......... 32
OTC Market Forecast ... 33
Table: Belgium’s OTC Drugs Market Indicators, 2006-2012 (US$mn unless otherwise stated) . 34
Generics Market Forecast ....... 35
Table: Belgium’s Generics Drug Market Indicators, 2006-2012 ........... 36
Export/Import Forecasts.......... 37
Table: Belgium’s Pharmaceuticals Exports And Imports, 2005-2012 (US$mn) .... 38
Other Healthcare Data Forecasts . 38
Table: Belgium’s Healthcare Data Indicators, 2005-2012 .. 38
Key Risks To BMI’s Forecasts . 38
Competitive Landscape ......39
Company Monitor .........40
Leading Multinational Manufacturers ................ 40
GlaxoSmithKline (GSK) 40
Pfizer ...... 42
Novartis .. 44
Sanofi-Aventis ............... 46
Merck & Co . 48
Leading Indigenous Manufacturers ... 50
UCB Pharma ................ 50
Solvay ..... 55
Janssen Pharmaceutica 59
Omega Pharma ............. 61
BMI Forecast Modelling ......62
How We Generate Our Pharmaceutical Industry Forecasts ..... 62
Pharmaceutical Industry.......... 63
Pharmaceutical Business Environment Ratings Methodology .. 63
Ratings Overview .......... 63
Table: Pharmaceutical Business Environment Indicators ... 64
Weighting 65
Table: Weighting Of Components . 65
Sources ........ 65
Belgium Pharmaceuticals And Healthcare Industry SWOT... 6
Belgium Political SWOT . 6
Belgium Economic SWOT.......... 7
Pharmaceutical Business Environment Ratings ..........8
Table: Western Europe Pharmaceutical Business Environment Ratings . 8
Limits Of Potential Returns........ 8
Belgium – Market Summary ...........10
Regulatory Regime .........11
Intellectual Property Developments............... 12
Pricing And Reimbursement Regime.............. 13
Pricing And Reimbursement Developments ... 14
Industry Developments .......16
Healthcare Sector ......... 16
Recent Healthcare Sector Developments ....... 17
Epidemiology ................ 18
Table: Disease Burden In Western Europe.... 19
Operating Environment And Recent Company Developments ............... 20
Generics Sector ............. 22
Research And Development Sector ................ 24
Industry Forecast Scenario ..25
Overall Market Forecast.......... 25
Table: Belgium’s Drug Market Indicators, 2005-2012........ 26
Key Growth Factors – Industry 27
Table: Belgium’s Health Expenditure Indicators, 2005-20 28
Key Growth Factors – Macroeconomic ......... 29
Table: Belgium - Economic Activity............... 31
Patented Market Forecast........ 32
Table: Belgium’s Patented Drugs Market Indicators, 2006-2012 .......... 32
OTC Market Forecast ... 33
Table: Belgium’s OTC Drugs Market Indicators, 2006-2012 (US$mn unless otherwise stated) . 34
Generics Market Forecast ....... 35
Table: Belgium’s Generics Drug Market Indicators, 2006-2012 ........... 36
Export/Import Forecasts.......... 37
Table: Belgium’s Pharmaceuticals Exports And Imports, 2005-2012 (US$mn) .... 38
Other Healthcare Data Forecasts . 38
Table: Belgium’s Healthcare Data Indicators, 2005-2012 .. 38
Key Risks To BMI’s Forecasts . 38
Competitive Landscape ......39
Company Monitor .........40
Leading Multinational Manufacturers ................ 40
GlaxoSmithKline (GSK) 40
Pfizer ...... 42
Novartis .. 44
Sanofi-Aventis ............... 46
Merck & Co . 48
Leading Indigenous Manufacturers ... 50
UCB Pharma ................ 50
Solvay ..... 55
Janssen Pharmaceutica 59
Omega Pharma ............. 61
BMI Forecast Modelling ......62
How We Generate Our Pharmaceutical Industry Forecasts ..... 62
Pharmaceutical Industry.......... 63
Pharmaceutical Business Environment Ratings Methodology .. 63
Ratings Overview .......... 63
Table: Pharmaceutical Business Environment Indicators ... 64
Weighting 65
Table: Weighting Of Components . 65
Sources ........ 65
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
